In August 2004, duloxetine hydrochloride (Cymbalta; Eli Lilly), a selective serotonin- and noradrenaline-reuptake inhibitor, was approved by the US FDA for the treatment of major depressive disorder.

Cymbalta (duloxetine) is a prescription drug that’s used to treat certain kinds of pain, depression, and other conditions. The drug comes as a delayed-release oral capsule. It’s usually taken once or ...

Duloxetine (Dumore (60 mg)) belongs to a class of drugs known as serotonin-norepinephrine reuptake inhibitors. It is prescribed for depression, generalized anxiety disorder and for managing chronic ...

INDIANAPOLIS, Aug. 21 -- New data suggest that patients with fibromyalgia treated with 60mg or 120mg of Cymbalta(R) (duloxetine HCl) experienced greater reduction in pain severity beginning one week ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The FDA recently approved duloxetine ...

INDIANAPOLIS, July 6, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity ...

February 19, 2008 (Kissimmee, FL) — Results of a randomized trial suggest that duloxetine (Cymbalta, Eli Lilly & Co) is safe and effective in the treatment of fibromyalgia, whether depressive symptoms ...

Lupin on Friday said it has received approval from the US health regulator to market Duloxetine Hydrochloride capsules, used to treat major depressive disorder, in the American market. The company has ...

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated December 13, 2013 titled "Aurobindo Pharma receives USFDA approval for Duloxetine Hydrochloride Delayed Release Capsules".

NEW DELHI: Drug major Lupin has launched generic anti-depressant drug Duloxetine in 40 mg strength in the US market. Lupin had earlier launched Duloxetine HCl DR Capsules in strengths of 20 mg, 30 mg ...